5 min readNov 6, 2026 03:06 PM IST
First published on: Nov 6, 2026 at 12:13 PM IST
As soon as her 20-month-old son was diagnosed with a rare thyroid disorder, Pavitra Sirolikar started researching about the condition and ways in which she could help him. She came to know of a medicine — first synthesised in 1953, but never approved in India — that could potentially reduce the debilitating effect of the disease.
She imported a month’s worth of medicine from Germany — under the country’s personal use exemptions — at a cost of nearly Rs 13 lakh. She knew this was not sustainable; her son would need the medicine as long as he lives.